AI health care

India Bets on Homegrown Healthtech: Mobilab Set to Revolutionize Point-of-Care Diagnostics.

Keywords:- Indian Startup, A.I, Health.

n a boost to India’s healthtech startup ecosystem, the Technology Development Board (TDB), Department of Science and Technology, has partnered with Primary Healthtech Pvt. Ltd., New Delhi, to scale up an IoT-enabled, AI/ML-powered point-of-care blood testing device for affordable and accessible healthcare.

Primary Healthtech, founded by IIT Guwahati alumni Sahil Jagnani and Ankit Choudhury, has emerged as a promising startup blending deep science, artificial intelligence, and product engineering. The company grew out of a multidisciplinary effort of doctors, researchers, and entrepreneurs focused on affordable diagnostics for underserved populations.

Keywords: ECG classification, CNN-LSTM, Genetic Algorithm, AI in healthcare, real-time ECG monitoring, cardiovascular disease detection, healthtech startup, feature optimization

Its flagship product, Mobilab, is a portable, battery-operated clinical chemistry analyzer that can test over 25 parameters related to kidney, liver, and heart functions, along with vitamins and cancer markers. Backed by IoT integration and AI-driven analysis, Mobilab brings the sophistication of a pathology lab into a compact device that works even in rural settings.

The startup already holds a patent transferred from IIT Guwahati on “A transmittance-based system/kit for point-of-care quantification” and has filed six additional patents covering optical systems, assay development, and microfluidic innovations. Mobilab has been tested on more than 10,000 patients and has secured a CDSCO manufacturing license, making it one of the few indigenous startups ready for scale in advanced diagnostics.

With TDB’s support, Primary Healthtech will now develop a next-generation version of Mobilab, capable of conducting five simultaneous tests to cut patient waiting times. This upgraded model will add critical parameters such as Hemoglobin, Creatinine, Bilirubin, Cholesterol, Triglycerides, Uric Acid, Glucose, and GGT. The project also aims to set up commercial-scale manufacturing, transforming the prototype into a market-ready, mass-produced device.

Sh. Rajesh Kumar Pathak, Secretary, TDB, highlighted the significance:
“Ensuring quality healthcare access in rural and remote regions is a national priority. This project not only addresses affordability and accessibility but also showcases India’s capability in developing indigenous, AI-powered diagnostic solutions for primary healthcare.”

The startup’s founders expressed their vision:
“TDB’s support will accelerate our journey from lab innovation to large-scale deployment. With Mobilab, we aim to bridge India’s healthcare gap by bringing AI-powered, point-of-care diagnostics to rural and underserved communities.”

This collaboration reflects how India’s startup ecosystem, deep-tech innovation, and government support are converging to build a new wave of indigenous medtech solutions, strengthening Atmanirbhar Bharat and positioning India as a global hub for affordable healthcare technologies.

Similar Posts